DSGN (STOCKS)
Design Therapeutics, Inc. Common Stock
$11.220000
+0.250000 (+2.28%)
Prev close: $10.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Pratik Shah
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $695.77M
- Employees
- 55
- P/E (TTM)
- -9.33
- P/B (TTM)
- 3.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.29 | $-0.33 | +0.0449 | +13.41% |
|
Dec 2025 (Q4)
|
$-0.27 | $-0.36 | +0.0911 | +25.23% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.35 | +0.0502 | +14.33% |
|
Jun 2025 (Q2)
|
$-0.34 | $-0.34 | -0.0034 | -1.01% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $78.76M |
| Research and Development | $58.13M |
| Other Operating Expenses | $20.62M |
| Operating Income/Loss | -$78.76M |
| Income/Loss From Continuing Operations After Tax | -$69.71M |
| Income/Loss From Continuing Operations Before Tax | -$69.71M |
| Net Income/Loss | -$69.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$69.71M |
| Net Income/Loss Available To Common Stockholders, Basic | -$69.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.20 |
| Diluted Earnings Per Share | -$1.20 |
| Basic Average Shares | 175,718,257 |
| Diluted Average Shares | 175,718,257 |
| Assets | $230.44M |
| Current Assets | $227.05M |
| Cash | $222.80M |
| Prepaid Expenses | $2.40M |
| Other Current Assets | $1.85M |
| Noncurrent Assets | $3.39M |
| Fixed Assets | $824.00K |
| Other Non-current Assets | $2.57M |
| Liabilities | $12.39M |
| Current Liabilities | $10.19M |
| Accounts Payable | $2.28M |
| Wages | $2.33M |
| Other Current Liabilities | $5.58M |
| Noncurrent Liabilities | $2.20M |
| Equity | $218.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $218.05M |
| Liabilities And Equity | $230.44M |
| Net Cash Flow From Operating Activities | -$54.00M |
| Net Cash Flow From Operating Activities, Continuing | -$54.00M |
| Net Cash Flow From Investing Activities | $7.45M |
| Net Cash Flow From Investing Activities, Continuing | $7.45M |
| Net Cash Flow From Financing Activities | $45.65M |
| Net Cash Flow From Financing Activities, Continuing | $45.65M |
| Net Cash Flow | -$897.00K |
| Net Cash Flow, Continuing | -$897.00K |
| Comprehensive Income/Loss | -$70.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$70.43M |
| Other Comprehensive Income/Loss | -$36.80M |